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M. LIMA*, M. T. SMITH†, C. SILVA*, A. ABADE‡, F. M. MAYER§ and
P. COUTINHO¶
*Department of Biology, University of the Azores, Portugal, †Department of
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Coimbra, Portugal, §Department of Biological Sciences, University of Quebec in
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Summary. Machado-Joseph Disease (MJD) is an autosomal dominant
neurodegenerative disorder of adult onset, associated with the expansion of a
(CAG)n tract in the coding region of the causative gene, localized on 14q32.1.
Machado-Joseph Disease shows non-Mendelian features typical of other
triplet repeat disorders, including clinical heterogeneity, variable age at onset
and anticipation. Three phenotypes have been proposed (clinical types 1, 2
and 3). Type 1 is associated with early age at onset and a high repeat number
of the CAG sequence, and Types 2 and 3 have later onset and lower numbers
of CAG repeats. This paper investigates whether there is selection against the
MJD gene, acting through diVerential survival, nuptiality and fertility
associated with clinical type and age at onset. The study sample comprised
40 MJD patients from the Azores (Portugal) having fully documented
reproductive histories and known dates of death. The proportion of married
patients of each clinical type increased from 0·22 among Type 1 patients, to
0·40 in Type 2 and 0·95 in Type 3. Age at onset and length of survival were
also associated with marital status, with the married cases having later mean
age at onset and longer mean survival time. In the whole sample, clinical type
was associated with fertility, with significantly fewer children born to Type 1
patients. Among married patients clinical type was not associated with age at
marriage, reproductive span or number of children. No reduction of fertility
was detected among married patients in whom the onset of MJD was below
the age of 50. The authors’ interpretation of these results is that the
high-repeat CAG haplotypes associated with early age at onset and clinical
Type 1 are selected against through reduced survival and fertility. The fertility
component of selection is mediated by nuptiality rather than marital fertility.
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Introduction
Machado-Joseph Disease is an autosomal dominant neurodegenerative disorder,
usually characterized by gait ataxia and limitation of eye movements, among a wide
range of clinical features, which all usually arise during adult life (OMIM 109150).
Coutinho (1992) observed a mean age at onset of 40·2 years in a large Portuguese
sample, but ages of onset ranging from 6 to 70 years have been reported (Coutinho,
1992; Sequeiros & Coutinho, 1993). There are a number of such disorders showing
late-onset neurodegeneration and dominant inheritance, the best known being
Huntington’s Disease. This combination of features is especially problematic for
families in which the disease occurs, since dominant inheritance implies that someone
with a parent carrying the gene has a 50% chance of inheriting it, and yet the late
onset means that an individual will frequently not know whether they themselves
carry the gene until after they have married and reproduced. Molecular diagnosis
before onset can remove this uncertainty, but brings its own problems (Meissen et al.,
1991; Decruyenaere et al., 1996).
From the earliest reports, MJD has been recognized as pleomorphic in its clinical
presentation (Nakano, Dawson & Spence, 1972; Woods & Schaumburg, 1972;
Rosenberg et al., 1976). On the basis of clinical presentation and age at onset, three
MJD phenotypes were proposed by Coutinho & Andrade (1978). Type 2 is the basic
presentation, with progressive ataxia, pyramidal signs and ophthalmoplegia, having a
mean age at onset of 40·5 years in the large Portuguese series studied by Coutinho
(1992). Type 1 is characterized by early onset (mean age 24·3 years; Coutinho, 1992)
with marked pyramidal and extrapyramidal signs. Type 3 has later onset (mean age
46·8 years; Coutinho, 1992), and is associated with additional distal muscular
atrophies and sensory loss.
The MJD locus has been assigned to the long arm of chromosome 14 (Takiyama
et al., 1993), and is associated with the expansion of a (CAG)n tract in the coding
region of the causative gene, localized on 14q32.1 (Kawaguchi et al., 1994). The
expansion of CAG repeats in coding regions is known to be a common feature of a
number of neurodegenerative disorders (Tsuji, 1996). Such ‘triplet repeat disorders’
share a number of characteristic features whose inheritance cannot be explained by
Mendelian principles, including clinical heterogeneity, variable age at onset, and
anticipation (earlier age at onset in successive generations).
The number of triplet repeats seems to influence aspects of clinical presentation,
particularly age at onset (Andrew et al., 1993; Snell et al., 1993; Koide et al., 1994;
Ranum et al., 1994). In MJD, a strong inverse correlation between the number of
triplet repeats and age at onset has been demonstrated (DeStefano et al., 1995; Dürr
et al., 1995; Maciel et al., 1995; Maruyama et al., 1995). Anticipation has been
reported by several authors studying diVerent series of patients (Maciel et al., 1995;
Sousa et al., 1997), and is associated with an expansion of triplet repeats between
parents and children, the diVerence in CAG repeat length being greater in paternal
than in maternal transmission. Type 1 MJD shows a larger degree of expansion in
CAG repeats than the other clinical types. It has also been reported that a patient
homozygous for the expanded triplet repeat had juvenile onset and more severe
symptoms of the disease (Lang et al., 1994; St-George-Hyslop et al., 1994; Takiyama
et al., 1995).
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A survey of MJD in the nine islands of the Azores (total population 237,795)
identified 103 cases, which represents a prevalence of 1 in 2309 individuals, and in the
Azorean island of Flores (population 4329) the disease has its highest worldwide
prevalence (Lima et al., 1997b), with 1 in 103 people aVected. Even though MJD is
now considered to be one of the most common autosomal dominant spinocerebellar
degenerations (Takiyama et al., 1993; Kawaguchi et al., 1994; Tsuji, 1996), it is clearly
over-represented in the Azores. As a comparative figure the nationwide survey of
Japanese patients by Hirayama et al. (1994) can be cited, which estimated a frequency
of about one MJD patient per million of population. The evolutionary processes
responsible for the high frequency of MJD in the Azores are most likely to be founder
eVect and genetic drift, as has previously been shown to be the case when high
frequencies of hereditary disorders occur in isolated populations (Morton, 1980;
O’Brien et al., 1988). However, a previous study has demonstrated that there is not
a unique set of founders for all Azorean MJD patients (Lima et al., 1998).
The main focus of this paper, however, is another evolutionary process, natural
selection. Analysis of other expansion disorders, namely Huntington’s Disease and
Spinocerebellar Ataxia Type 1 (Frontali et al., 1996), has suggested that natural
selection may act against the MJD gene through the diVerential fitness of CAG repeat
length in the causative genes. Under the model proposed by Frontali et al. (1996),
most of the alleles with the largest expansions are lost at each generation and are
replaced by those in the low/medium expansion range. Such a mechanism of selective
loss of the largest numbers of repeats would be expected to balance the inter-
generational expansion of triplet repeats reported above. A case-control survey of
MJD families undertaken to discover whether natural selection acted in the same way
in MJD found no reduction in their reproductive output compared with unaVected
families (Lima et al., 1997a). That survey was limited, by the study design, to the
fertility of married MJD patient controls, and could not consider whether MJD
patients survived and married at the same rate as unaVected individuals.
The purpose of the present study is to take a series of clinically diagnosed MJD
patients for whom complete reproductive histories have been recorded, and to test for
associations between the clinical features of the disease phenotype and survival,
nuptiality and marital fertility. The variables subsumed in the clinical features include
clinical type and two of its components: age at onset and length of survival. The
hypothesis is that in a disease of this nature, of variable but generally late age at
onset, and imposing no apparent physiological or biological limitation on reproduc-
tion, reduction in fitness will usually be mediated by social behaviour. In cases of
exceptionally early onset, however, it might occur that the suVerer died or became
incapacitated before the normal age at marriage, thus obviating the behavioural
component of selection. Behavioural selection against the MJD gene may occur if
someone who already has the disease, or someone who is an undiagnosed member of
an MJD family, is unwilling or unable to marry. Additionally, selection may occur if
the disease develops in a patient who is married but still of reproductive age, and the
couple decide to curtail their reproduction at that point.
Such behavioural choices will be to an extent the prerogative of individuals and
couples, but will also be subject to societal norms of behaviour, through the reported
stigma attaching to undiagnosed members of MJD families, as well as to those
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already showing symptoms (Boutté, 1987). The authors suggest that through these
mechanisms the gene may influence the fitness of its carriers, and hence predict an
association between the clinical features of MJD patients and their reproductive
success. They predict that clinical type, and age at onset in particular, will aVect
survival, nuptiality and marital fertility.
Methods
The series studied comprised 40 clinically confirmed MJD patients born in the
Azores between 1901 and 1979, for whom dates of birth, marriage (if applicable) and
death were available. The sample of patients analysed corresponded to all patients
for whom there was a complete set of data at the time of the study. Of the
40 patients, 28 were married, and their complete reproductive history was fully
documented. Cross-checking among the various genealogical sources, both oral and
written, showed that, as far as could be ascertained, the unmarried patients had no
children. This sample represented, at the time of the study, the largest group of
individuals for whom all pertinent data were available. For the married patients the
following demographic variables were calculated: age at marriage, number of
oVspring and duration of reproductive span (number of years between marriage and
birth of the last child). The information was obtained from an extensive demo-
graphic and genealogical database of the Azorean MJD families built at the
University of the Azores. The database and the software used for the analysis
(ANALYPOP) were developed by E. Labelle under the supervision of F. M. Mayer
(University of Quebec in Montreal) and have been described in detail in Lima et al.
(1997b).
The diagnosis of MJD was determined by clinical examination by an experienced
neurologist, using established diagnostic criteria (Lima & Coutinho, 1980). Age at
onset, clinical type (assigned according to the classification proposed by Coutinho &
Andrade (1978)) and survival time (number of years between age at onset and time
of death) were the clinical variables describing the phenotypic heterogeneity of MJD.
After testing for associations between demographic and clinical variables the
consistency of the present sample with the larger Portuguese series studied by
Coutinho (1992) was established to give confidence in the wider applicability of the
results.
Results
Table 1 shows the characteristics of the sample divided by clinical type. Type 1
patients had a mean age of onset of 23·2 years, significantly younger than Type 2
(t= "2·96, p=0·01) and Type 3 (t= "5·89, p=0·000). Age at onset of Type 2 was 42·1
years, and that of Type 3 was 50·9 years, but the diVerence between them was not
significant (t= "1·76, p=0·104). Among the whole sample, survival time was 12·1
years in Type 1 patients, significantly shorter than that of Type 3, who survived for
an average of 16·7 years. The survival of Type 2 patients, at 13·0 years, was not
significantly diVerent from either Type 1 (t= "0·34, p=0·740) or Type 3 (t= "1·65,
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Table 1. Clinical type and demographic features of MJD patients
Clinical type














Type 1 9 23·2 24·3 0·22 12·1 0·56 2 23·5 34·5 17·0 12·0 2·50
Type 2 10 42·1 40·5 0·40 13·0 2·40 6 23·5 37·3 12·2 7·2 2·40
Type 3 21 50·9 46·8 0·95 16·7 3·48 20 24·8 50·5 17·0 11·4 3·48




t test t test t test t test Mann–
Whitney U
Type 1 vs Type 2 ** *** — — — * — — —
Type 1 vs Type 3 *** * ** — ** — — —
Type 2 vs Type 3 — — — — — — — —
aValues from Coutinho (1992).










p=0·110). Among the married cases there were no significant diVerences in survival
time between the clinical types.
The proportion of married patients of each clinical type increased from 0·22
among Type 1 patients, to 0·40 in Type 2 and 0·95 in Type 3. This association of
marital status with clinical type was statistically significant (Kendall’s ô="0·615,
p=0·000). The association of marital status with clinical type means that some of the
components of clinical type, namely age at onset and length of survival, were also
associated with marital status, with the married cases having a later mean age at onset
(46·5 years versus 33·1, t=2·13, p=0·05) and longer mean survival time (16·0 years
versus 11·8, t=2·61, p=0·01).
Table 1 shows that when the whole sample, both married and unmarried, was
considered the mean number of children per patient was also related to clinical type,
with significantly fewer children born to Type 1 than to Type 3 (Mann–Whitney
U=43·5, p=0·010). The diVerences in the number of children born to Type 2 and
Type 3 patients, and to Type 1 and Type 2 patients, were not statistically significant,
with U=97·0 (p=0·499) and U=25·5 (p=0·113) respectively.
To explore the relationship between age at onset, age at death and marital status,
age at death for all cases is plotted against their age at onset of MJD in Fig. 1. The
mean age at marriage was 24·4 years. The sample included three cases of childhood
onset, at ages 5, 6 and 8 years, who died at ages 13, 18 and 15 years respectively.
There were a further nine cases with onset below the age of 35 (these will be referred
to as ‘early-onset’ cases), of whom five (56%) remained unmarried. There were 28
cases with onset at 35 years of age or more (‘late-onset’ cases), and of these four
(14%) were unmarried. Leaving aside the three juvenile-onset cases, there was a
significant association between early and late onset and marital status (÷2=6·3,
Fig. 1. Machado-Joseph Disease profile by marital status.
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p=0·01). In order to illustrate further the importance of early onset in inhibiting
marriage, age at marriage is plotted against age at onset in Fig. 2. The trend line
shows where the data points would fall if age at marriage were equal to age at onset.
In fact the mean age at onset (42·5&15·7) was much higher than mean age at
marriage (24·4&4·9) but there was some overlap between their distributions.
Nevertheless, all the data points lie below the trend line, indicating that there were no
cases in which marriage occurred after onset.
There were 28 married patients, so testing for associations with clinical type within
this group was hampered by small sample sizes. The aim of the study was to discover
whether termination of reproduction at onset of MJD symptoms caused any
diVerence in marital fertility between the clinical types. Table 1 shows that there was
no diVerence in age at marriage between the three clinical types. Type 3 patients,
however, had a significantly later age at onset than Type 1 (t= "2·58, p=0·018) and
Type 2 (t= "2·87, p=0·008), while Type 1 and 2 did not diVer in age at onset
(t= "0·78, p=0·789). There was thus on average a longer period between marriage
and disease onset among Type 3 patients than among Types 1 and 2. However, no
association between clinical type and length of survival or reproductive span of the
married patients was detected. Nor was there any diVerence in the number of children
born to patients of each clinical type. For Type 1 versus Type 2 U=3·5 (p=0·429), for
Type 1 versus Type 3 U=17·0 (p=0·779), and for Type 2 versus Type 3 U=53·0
(p=0·700).
In order to explore further the question of whether marital fertility might have
been curtailed by couples deciding not to have more children after the onset of MJD
in one partner, the following additional test was devised. On the assumption that
reproduction is naturally completed by the age of 50, the sample of married patients
was divided into two groups: those with onset below 50 years of age, and those with
onset at 50 years or more. If onset of the disease after marriage led people to stop
having children whilst still of reproductive age, a smaller mean family size in the
Fig. 2. Age at marriage in relation to age at onset of MJD.
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‘onset under 50’ age group would be predicted. There was no such eVect either on
reproductive span (t= "0·679, p=0·5052) or on family size, with an average of 3·53
children born to the ‘onset under 50’ group and 3·77 to the ‘onset at 50 and over’
group (Mann–Whitney U=75·0, p=0·8242).
Comparison of the results presented here with data from Coutinho (1992) shows
consistency in the proportion of clinical types, with just over half the patients
presenting with Type 3 MJD. Average age at onset in the present study was 42·5 years
(range 5 to 66 years), with a mean duration of 14·7 years, slightly shorter than
observed by Coutinho (1992). This discrepancy can perhaps be explained by the
inclusion in the present study of the childhood-onset cases with their short life span.
In the present sample, there is a marginally later age at onset of Types 2 and 3 than
in Coutinho (1992): 42·1 years versus 40·5 years for Type 2 and 50·9 years versus 46·8
years for Type 3. This may be due to chance or might reflect slight diVerences in
diagnostic practice. Although the age at marriage of MJD patients in this study was
in accordance with previously published data, the mean number of oVspring (3·6) was
lower than previously reported (Lima et al., 1997a). The earlier study had included
96 unions involving an MJD patient, marriages that took place in the Azores between
1850 and 1950, producing an average of 6·3 children per couple. The authors believe
that the discrepancy in family size can be attributed to the later period of marriage
(1921–1970) in the present study. Livi Bacci (1971) has recorded a decline in marital
fertility in Portugal from the mid-nineteenth century, and Rocha (1991) has
documented the twentieth century reduction in marital fertility in the Azores.
Although the number of marriages per decade is very small, even within these data,
this decline is detectable, falling from 7·5 children per marriage in the 1920s to 3·7,
3·2 and 3·6 in subsequent decades, and reaching an average of 2·6 in the 1960s. The
general agreement between the results reported here and by Coutinho (1992) and
Lima et al. (1997b) suggests that the patients analysed in the present study are
representative of Portuguese cases in general.
Discussion
There are two mechanisms by which this selection occurred: firstly, and only
occasionally, there were juvenile-onset cases who died before reproductive age, and
secondly, there were those who lived long enough to marry but failed to do so. Figure
1 shows that for the juvenile-onset cases, the disease itself was an eVective barrier to
survival and reproduction apparently without any need to invoke the moderating
eVect of marriage. The juvenile-onset cases died at ages 13, 15 and 18, however, whilst
the youngest age at marriage in the sample was 17 years. This suggests that although
the mechanisms may be categorically distinct, there can be an overlap between their
operation in practice, with juvenile-onset cases who survive long enough to reach
marriageable age remaining unmarried notwithstanding their maturity.
For those patients who did not marry, even though they survived until adulthood,
there are a number of possible explanations for their celibacy. They might simply
happen not to have married, just as a proportion of the unaVected population would
have remained single. The proportion of unmarried patients was too high at 43% (or
32% if those with childhood onset who died by 18 years of age are discounted) for
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this to be an adequate explanation for all cases. Celibacy rates for the general and
regional Portuguese population (Livi Bacci, 1971) show that in the period 1900–1960
the proportion of single females aged 50–54 years fell from 21·4% to 16%, with the
proportion of men declining from 13% to 10·4%. Figures for the proportion of single
females aged 50–54 years within the Azores were slightly higher than these general
figures in the administrative district of Angra and slightly lower in the district of
Ponta Delgada. In view of these rates, it seems likely that ‘natural’ celibacy can
provide only a partial explanation for the large proportion of unmarried MJD
patients.
The unmarried patients might have intended to marry, but failed to do so because
the onset of the disease came before they had chosen a partner, and once symptoms
appeared they or their potential mates decided against marriage. Alternatively, they
might have remained celibate regardless of age of onset, either by their own choice,
restrained by the knowledge that they were at risk of developing MJD, or avoided as
marriage partners by others for the same reason. Celibacy in these situations can be
referred to as either ‘symptom-based’ or ‘restraint-based’. These possibilities can be
distinguished by referring to Fig. 1. If fear of later occurrence were as potent a
deterrent to marriage as the development of symptoms itself, no diVerence in the
distribution of age at onset between the married and unmarried cases would be
expected. It can be recalled, however, that there was a skewing of unmarried cases
towards early age at onset, with 56% unmarried in the group with onset below 35
years of age compared with only 14% unmarried among those with onset at 35 years
of age or more. This discrepancy in proportions suggests that at least some of those
unmarried cases with MJD onset at ages 27, 29, 31, 33 and 34 were single people
within the normal range of age at marriage whose intention had been to marry, but
who were prevented from doing so by onset of the disease. Unfortunately, these data
do not allow complete confidence in this judgement, since in general the age at
marriage in this sample was lower than the age at onset of the disease.
There is circumstantial evidence of such behaviour in the distributions of age at
marriage and age at onset of MJD. Figure 2 shows these data plotted for each of the
married cases. Although the mean age at onset (42·5&15·7) was much higher than
mean age at marriage (24·4&4·9), as stated previously, there was considerable overlap
between their distributions. Yet there were no cases in which marriage occurred after
onset. This can be interpreted to indicate that people did not get married once the
symptoms of MJD had become apparent. The skewing of the unmarried cases
towards the earlier age of onset, together with the fact that there was no case in which
marriage took place after onset, implies that for the early-onset cases onset of the
disease played a part in the decision not to marry. In practice, perhaps some of the
early-onset unmarried cases had delayed marriage in case symptoms developed, only
to be confirmed in their celibacy at the onset of MJD. In such a case ‘restraint-based
celibacy’ would be overtaken by ‘symptom-based celibacy’ later in life. With regard
to the later-onset unmarried cases it is assumed that their condition is a combination
of ‘natural’ celibacy perhaps together with some element of restraint, though it might
be questioned whether ‘natural’ celibacy is a state consistent with the consciousness
of being at risk. In a dataset of this sort it is impossible to identify the reason why
any particular individual remained unmarried, and it is diYcult to attribute celibacy
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exclusively to one or other cause, since once symptoms of MJD have developed the
concepts of ‘restraint-based’ and ‘natural’ celibacy can no longer apply. Thus, as has
been seen in the case of juvenile-onset cases living to marriageable age, one cause may
give way to another during the life course.
For the second prediction, that clinical type and age of onset would reduce marital
fertility through the premature cessation of reproduction after onset of symptoms, no
support was found. Comparison of the number of children born to married patients
of the three clinical types showed no diVerence in reproductive output between them,
even though the Type 3 patients survived significantly longer on average than Types
1 and 2. Furthermore, the test devised to examine the eVects of disease status in
cutting short the reproduction of married patients after onset showed no diVerence in
family size between those with onset during the reproductive period and those with
onset after the age of 50. At a descriptive level the subject of age at onset and
continued procreation can be pursued still further. Among the seven married patients
with age at onset of 35 years or younger, the mean family size was 4·00, and among
the four in whom the disease started before the age of 35, mean family size was 4·50.
Thus, no evidence was found that early onset of the disease after marriage led to a
reduction in marital fertility, even though reproduction continued after onset of the
disease in only three cases.
The authors’ interpretation of these data is that selection against MJD is mediated
by marital status alone, rather than through reduction of marital fertility. It is not
clear at what stage the decision not to marry takes place. In some cases, it may be
that the development of symptoms prevents marriage; in others, that the family legacy
of MJD reduces the likelihood of marriage, either through self-imposed restraint, or
through an aversion exercised by potential marriage partners. The case-control
approach used by Lima et al. (1997b) might be used to confirm this finding if
reproductive output could be measured in terms of the number of grandchildren
rather than children, though in view of the diYculty in calculating pedigrees to this
level in a population with such a high emigration rate as the Azores, a surrogate
measure such as ‘children who marry’ could be taken as an alternative. Another
approach would be to compare the nuptiality and reproductive success of aVected
individuals with that of their unaVected sibs.
To summarize, the results show that clinical type is associated with reproductive
success, as predicted. However, this eVect appears to be entirely due to the lower rate
of marriage among Type 1 MJD patients. Among married patients there was no
dependence of fertility on clinical type or age at onset. In other words, natural
selection against the MJD gene seems to have operated solely through the lack of
reproductive success of the unmarried cases.
These results have significance for the debate about the regulation of the number
of CAG repeats, and the assessment of the number of CAG repeats in Azorean MJD
patients will provide the opportunity to integrate molecular features with their
reproductive and clinical characteristics. Frontali et al. (1996) proposed a model of
selective loss in each generation of the majority of alleles with the largest number of
repeats and their replenishment by the expansion of alleles in the low-to-medium
repeat range. Such a mechanism of selective elimination of the largest CAG repeat
numbers is entirely consistent with the results of the present study, which has
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demonstrated natural selection against early-onset forms of MJD associated with the
most highly repeated CAG sequences.
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